Search

everythinglearnresearchcommunity

for

Search:↓

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

Golden oyster mushroom extract may protect skin cells from aging by its antioxidant properties.

The protein aPKCλ is crucial for keeping hair follicle stem cells inactive and for hair growth and regeneration.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Stem cells can rejuvenate skin, restore hair, and aid in wound healing.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

3D bioprinting could improve skin repair and treat conditions like vitiligo and alopecia by precisely placing cells.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Key genes linked to hair growth and cancer were identified in hairless mice.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

A gene mutation worsens skin irritation in mice due to a lack of certain fats.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

MicroRNAs are crucial for skin development, regeneration, and disease treatment.

Water extract of Cacumen Platycladi helps hair growth by activating specific cell pathways.